401 related articles for article (PubMed ID: 20027941)
41. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
42. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
Langner A; Sheehan-Dare R; Layton A
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
[TBL] [Abstract][Full Text] [Related]
43. Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade I acne vulgaris.
Biswas S; Mondal KK; Dutta RN; Sarkar DK
J Indian Med Assoc; 2009 Apr; 107(4):219-22. PubMed ID: 19810365
[TBL] [Abstract][Full Text] [Related]
44. Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen.
Pariser D; Bucko A; Fried R; Jarratt MT; Kempers S; Kircik L; Lucky AW; Rafal E; Rendon M; Weiss J; Wilson DC; Rossi AB; Ramaswamy R; Nighland M
J Drugs Dermatol; 2010 Jul; 9(7):805-13. PubMed ID: 20677537
[TBL] [Abstract][Full Text] [Related]
45. A comparative review of the efficacy and tolerability of retinoid-containing combination regimens for the treatment of acne vulgaris.
Campbell JL
J Drugs Dermatol; 2007 Jun; 6(6):625-9. PubMed ID: 17668528
[TBL] [Abstract][Full Text] [Related]
46. Benzoyl peroxide-based combination therapies for acne vulgaris: a comparative review.
Taylor GA; Shalita AR
Am J Clin Dermatol; 2004; 5(4):261-5. PubMed ID: 15301572
[TBL] [Abstract][Full Text] [Related]
47. [Topical treatment of acne].
Auffret N
Rev Prat; 2002 Apr; 52(8):854-7. PubMed ID: 12053794
[TBL] [Abstract][Full Text] [Related]
48. Topical retinoid and antibiotic combination therapy for acne management.
Weiss JS; Shavin JS
J Drugs Dermatol; 2004; 3(2):146-54. PubMed ID: 15098969
[TBL] [Abstract][Full Text] [Related]
49. Comparative efficacy and safety results of two topical combination acne regimens.
Kircik LH
J Drugs Dermatol; 2009 Jul; 8(7):624-30. PubMed ID: 19588638
[TBL] [Abstract][Full Text] [Related]
50. Overall results of the BEST study following treatment of patients with mild to moderate acne.
Weiss J; Shavin J; Davis MW
Cutis; 2003 Feb; 71(2 Suppl):10-7. PubMed ID: 12630670
[TBL] [Abstract][Full Text] [Related]
51. Potential role for a new combination topical therapy in treating mild to moderate acne vulgaris.
Tschen E
Cutis; 2001 Feb; 67(2 Suppl):25-7. PubMed ID: 11236212
[TBL] [Abstract][Full Text] [Related]
52. Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination.
Bikowski JB
J Drugs Dermatol; 2005; 4(2):164-71. PubMed ID: 15776773
[TBL] [Abstract][Full Text] [Related]
53. Antibiotic resistance and acne: where we stand and what the future holds.
Bowe WP
J Drugs Dermatol; 2014 Jun; 13(6):s66-70. PubMed ID: 24918574
[TBL] [Abstract][Full Text] [Related]
54. Study design and selection criteria in the BEST study.
Rist T; Davis MW
Cutis; 2003 Feb; 71(2 Suppl):5-9. PubMed ID: 12630669
[TBL] [Abstract][Full Text] [Related]
55. Topical Vehicle Formulations in the Treatment of Acne.
Hoffman LK; Bhatia N; Zeichner J; Kircik LH
J Drugs Dermatol; 2018 Jun; 17(6):s6-s10. PubMed ID: 29879262
[TBL] [Abstract][Full Text] [Related]
56. Acne therapy.
White GM
Adv Dermatol; 1999; 14():29-58; discussion 59. PubMed ID: 10643494
[No Abstract] [Full Text] [Related]
57. Changing the face of acne therapy.
Ghali F; Kang S; Leyden J; Shalita AR; Thiboutot DM
Cutis; 2009 Feb; 83(2 Suppl):4-15. PubMed ID: 19363873
[TBL] [Abstract][Full Text] [Related]
58. Improving compliance in acne treatment: benzoyl peroxide considerations.
Draelos ZD
Cutis; 2008 Nov; 82(5 Suppl):17-20. PubMed ID: 19202774
[TBL] [Abstract][Full Text] [Related]
59. Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction.
Leyden J
Cutis; 2001 Feb; 67(2 Suppl):5-7. PubMed ID: 11236213
[TBL] [Abstract][Full Text] [Related]
60. Advances in topical delivery systems in acne: new solutions to address concentration dependent irritation and dryness.
Ceilley RI
Skinmed; 2011; 9(1):15-21. PubMed ID: 21409958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
